Literature DB >> 8944544

Scleral matrix metalloproteinases, serine proteinase activity and hydrational capacity are increased in myopia induced by retinal image degradation.

B E Jones1, E W Thompson, W Hodos, R J Waldbillig, G J Chader.   

Abstract

In the avian model of myopia, retinal image degradation quickly leads to ocular enlargement. We now give evidence that regionally specific changes in ocular size are correlated with both biomechanical indices of scleral remodeling, e.g. hydration capacity and with biochemical changes in proteinase activities. The latter include a 72 kDa matrix metalloproteinase (putatively MMP-2), other gelatin-binding MMPs, an acid pH MMP and a serine protease. Specifically, we have found that increases in scleral hydrational capacity parallel increases in collagen degrading activities. Gelatin zymography reveals that eyes with 7 days of retinal image degradation have elevated levels (1.4-fold) of gelatinolytic activities at 72 and 67 kDa M(r) in equatorial and posterior pole regions of the sclera while, after 14 days of treatment, increases are no longer apparent. Lower M(r) zymographic activities at 50, 46 and 37 kDa M(r) are collectively increased in eyes treated for both 7 and 14 days (1.4- and 2.4-fold respectively) in the equator and posterior pole areas of enlarging eyes. Western blot analyses of scleral extracts with an antibody to human MMP-2 reveals immunoreactive bands at 65, 30 and 25 kDa. Zymograms incubated under slightly acidic conditions reveal that, in enlarging eyes, MMP activities at 25 and 28 kDa M(r) are increased in scleral equator and posterior pole (1.6- and 4.5-fold respectively). A TIMP-like protein is also identified in sclera and cornea by Western blot analysis. Finally, retinal-image degradation also increases (approximately 2.6-fold) the activity of a 23.5 kDa serine proteinase in limbus, equator and posterior pole-sclera that is inhibited by aprotinin and soybean trypsin inhibitor. Taken together, these results indicate that eye growth induced by retinal-image degradation involves increases in the activities of multiple scleral proteinases that could modify the biomechanical properties of scleral structural components and contribute to tissue remodeling and growth.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8944544     DOI: 10.1006/exer.1996.0127

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  14 in total

1.  Change in the synthesis rates of ocular retinoic acid and scleral glycosaminoglycan during experimentally altered eye growth in marmosets.

Authors:  David Troilo; Debora L Nickla; James R Mertz; Jody A Summers Rada
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-05       Impact factor: 4.799

Review 2.  Regulation of scleral fibroblast differentiation by bone morphogenetic protein-2.

Authors:  Hong-Hui Li; Li-Jun Huo; Zhen-Ya Gao; Feng Zhao; Jun-Wen Zeng
Journal:  Int J Ophthalmol       Date:  2014-02-18       Impact factor: 1.779

3.  Hypoxia-Induced Scleral HIF-2α Upregulation Contributes to Rises in MMP-2 Expression and Myopia Development in Mice.

Authors:  Wenjing Wu; Yongchao Su; Changxi Hu; Huixin Tao; Ying Jiang; Guandong Zhu; Jiadi Zhu; Ying Zhai; Jia Qu; Xiangtian Zhou; Fei Zhao
Journal:  Invest Ophthalmol Vis Sci       Date:  2022-07-08       Impact factor: 4.925

4.  Inhibition of human scleral fibroblast cell attachment to collagen type I by TGFBIp.

Authors:  Lilian Shelton; Jody A Summers Rada
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-04-22       Impact factor: 4.799

5.  The FGF2 gene in a myopia animal model and human subjects.

Authors:  Jianhong An; Edward Hsi; Xiangtian Zhou; Yijin Tao; Suh-Hang Hank Juo; Chung-Ling Liang
Journal:  Mol Vis       Date:  2012-02-16       Impact factor: 2.367

6.  Scleral cross section area and volume and axial length.

Authors:  Jost B Jonas; Leonard Holbach; Songhomitra Panda-Jonas
Journal:  PLoS One       Date:  2014-03-28       Impact factor: 3.240

7.  Role of Chronic Inflammation in Myopia Progression: Clinical Evidence and Experimental Validation.

Authors:  Hui-Ju Lin; Chang-Ching Wei; Ching-Yao Chang; Ter-Hsin Chen; Yu-An Hsu; Yi-Ching Hsieh; Hsuan-Ju Chen; Lei Wan
Journal:  EBioMedicine       Date:  2016-07-19       Impact factor: 8.143

8.  Evaluation of MMP2 as a candidate gene for high myopia.

Authors:  Bo Gong; Xiaoqi Liu; Dingding Zhang; Pu Wang; Lulin Huang; Ying Lin; Fang Lu; Shi Ma; Jing Cheng; Rong Chen; Xiaobo Li; He Lin; Guangqun Zeng; Xiong Zhu; Jianbin Hu; Zhenglin Yang; Yi Shi
Journal:  Mol Vis       Date:  2013-01-28       Impact factor: 2.367

9.  Hepatocyte growth factor and myopia: genetic association analyses in a Caucasian population.

Authors:  Tammy Yanovitch; Yi-Ju Li; Ravikanth Metlapally; Diana Abbott; Khanh-Nhat Tran Viet; Terri L Young
Journal:  Mol Vis       Date:  2009-05-20       Impact factor: 2.367

10.  Bone morphogenetic protein-2: a potential regulator in scleral remodeling.

Authors:  Jianmin Hu; Dongmei Cui; Xiao Yang; Shaowei Wang; Shoulong Hu; Chuanxu Li; Junwen Zeng
Journal:  Mol Vis       Date:  2008-12-18       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.